FilingReader Intelligence
Metropolis Healthcare reports 23% revenue growth in Q1
August 14, 2025 at 04:39 PM UTC•By FilingReader AI
Metropolis Healthcare reported 23% revenue growth for Q1 FY26, driven by 13.2% organic growth. Organic B2C revenue increased 16% year-on-year, with EBITDA margin at 24.7%.
The company acquired Ambika Diagnostics for INR 17 crores and is integrating recent acquisitions to unlock synergies.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
BSE:METROPOLIS•Bombay Stock Exchange
News Alerts
Get instant email alerts when Metropolis Healthcare publishes news
Free account required • Unsubscribe anytime